ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 118 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $517,348 | -22.0% | 112,467 | +9.5% | 0.09% | -24.8% |
| Q2 2023 | $663,281 | -13.4% | 102,675 | +1.1% | 0.12% | -18.2% |
| Q1 2023 | $765,589 | -24.6% | 101,537 | +1.4% | 0.15% | -29.5% |
| Q4 2022 | $1,014,783 | +4.5% | 100,176 | +2.1% | 0.21% | 0.0% |
| Q3 2022 | $971,000 | -9.3% | 98,150 | -2.4% | 0.21% | -7.9% |
| Q2 2022 | $1,070,000 | +6.6% | 100,515 | -2.4% | 0.23% | +39.9% |
| Q1 2022 | $1,004,000 | -26.8% | 102,963 | +7.3% | 0.16% | -25.9% |
| Q4 2021 | $1,371,000 | +75.5% | 95,915 | +146.1% | 0.22% | +40.1% |
| Q3 2021 | $781,000 | – | 38,974 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |